Covance, Inc
Article Abstract:
The price appreciation potential of the shares of Covance Inc. for the years 2010-2012 is discussed. The Princeton, New Jersey-based company is one of the world's leading contract research organizations, and benefits from development outsourcing demand in the pharmaceutical industry.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2008
User Contributions:
Comment about this article or add new information about this topic:
Stock highlight: Covance, Inc. (CVD-38.58)
Article Abstract:
A leading contract research organization, Covance, is into marketing pre-clinical lab services to large pharmaceutical companies. They also undertake toxicology studies. A debt-free balance sheet, robust cash flow and over $144 million in cash assets make the stock attractive.
Publication Name: The Value Line Investment Survey (Part 2 - Selection & Opinion)
Subject: Business, general
ISSN:
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
Mylan Inc
Article Abstract:
The shares of Mylan Inc. have a substantial price appreciation potential over the 2010-2012 timeframe. The Canonsburg, Pennsylvania-based company is a manufacturer of prescription generic drugs and brand-name dermatological products.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2008
User Contributions:
Comment about this article or add new information about this topic: